QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis CaseStudy_CD155 Expression in Metastatic Melanoma and Anti-PD1 resistance
531 views
In this video, Eric Seiser, Ph.D, Sr. Field Application Scientist will be demonstrating a use case of QIAGEN Ingenuity Pathway Analysis for interpreting the biology of gene expression based omics dataset. The focus will be on a recent study on a potential therapeutic target CD155 for Metastatic Melanoma patients that demonstrate resistance to Anti-PD1 based therapies
Related videos
QIAGEN IPA
QIAGEN IPA deep-dive and new features training, America - Nov 3 2021
As requested by many users, your QIAGEN Digital Insights team is excited to...
QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis (IPA): Deep-dive trainings- July 21 2021
As requested by many users, your QIAGEN Digital Insights team is excited to...
QIAGEN IPA
New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity...
This 90-minute training session is for new users of QIAGEN IPA. Users will...
QIAGEN IPA
New user training: Large dataset analysis and knowledgebase queries using QIAGEN IPA- February 17
In this 90-minute video, users will take a deeper dive into core analysis,...